# Panbela Therapeutics Inc. (PBLA)

Source: https://www.quantisnow.com/company/PBLA
Generated: 2026-11-17T23:18:09.751Z

- Ticker: PBLA
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: Pharmaceutical Preparations
- Website: panbela.com

## About

Panbela Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing disruptive therapeutics for the treatment of patients with cancer. The company focuses on diseases of the pancreas, including pancreatitis and pancreatic cancer. Its lead product candidate is SBP-101, which is in Phase 1a/1b clinical trial for the treatment of patients with metastatic pancreatic ductal adenocarcinoma. The company was formerly known as Sun BioPharma, Inc. and changed its name to Panbela Therapeutics, Inc. in December 2020. Panbela Therapeutics, Inc. was founded in 2011 and is based in Waconia, Minnesota.

## Latest PBLA news and filings

- 2025-02-18 21:32 UTC [SEC Form 8-K] [Panbela Therapeutics Inc. filed SEC Form 8-K: Leadership Update](https://www.quantisnow.com/insight/panbela-therapeutics-inc-filed-sec-form-8-k-leadership-update-5894429)
- 2025-02-04 21:02 UTC [SEC Form 8-K] [Panbela Therapeutics Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits](https://www.quantisnow.com/insight/panbela-therapeutics-inc-filed-sec-form-8-k-leadership-update-financial-5869784)
- 2025-01-22 21:02 UTC [SEC Form 8-K] [Panbela Therapeutics Inc. filed SEC Form 8-K: Events That Accelerate or Increase a Direct Financial Obligation, Changes in Control of Registrant](https://www.quantisnow.com/insight/panbela-therapeutics-inc-filed-sec-form-8-k-events-that-accelerate-5853372)
- 2025-01-10 21:50 UTC [SEC Form S-8] [SEC Form S-8 filed by Panbela Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-s-8-filed-by-panbela-therapeutics-inc-5842255)
- 2024-11-19 23:40 UTC [SEC Form 4] [SEC Form 4 filed by Large owner Nant Capital, Llc](https://www.quantisnow.com/insight/sec-form-4-filed-by-large-owner-nant-capital-llc-5783770)
- 2024-11-18 22:05 UTC [SEC Form 424B3] [SEC Form 424B3 filed by Panbela Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-424b3-filed-by-panbela-therapeutics-inc-5781196)
- 2024-11-18 22:04 UTC [SEC Form 424B3] [SEC Form 424B3 filed by Panbela Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-424b3-filed-by-panbela-therapeutics-inc-5781189)
- 2024-11-18 22:03 UTC [SEC Form 424B3] [SEC Form 424B3 filed by Panbela Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-424b3-filed-by-panbela-therapeutics-inc-5781185)
- 2024-11-18 22:02 UTC [SEC Form 424B3] [SEC Form 424B3 filed by Panbela Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-424b3-filed-by-panbela-therapeutics-inc-5781174)
- 2024-11-18 22:01 UTC [SEC Form 424B3] [SEC Form 424B3 filed by Panbela Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-424b3-filed-by-panbela-therapeutics-inc-5781165)
- 2024-11-18 22:00 UTC [SEC Form 424B3] [SEC Form 424B3 filed by Panbela Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-424b3-filed-by-panbela-therapeutics-inc-5781150)
- 2024-11-18 21:59 UTC [SEC Form 424B3] [SEC Form 424B3 filed by Panbela Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-424b3-filed-by-panbela-therapeutics-inc-5781139)
- 2024-11-18 21:16 UTC [SEC Form 8-K] [Panbela Therapeutics Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Unregistered Sales of Equity Securities, Changes in Control of Registrant, Financial Statements and Exhibits](https://www.quantisnow.com/insight/panbela-therapeutics-inc-filed-sec-form-8-k-entry-into-a-5780820)
- 2024-11-15 11:15 UTC [SEC Form 424B3] [SEC Form 424B3 filed by Panbela Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-424b3-filed-by-panbela-therapeutics-inc-5778017)
- 2024-11-15 11:00 UTC [SEC Form 424B3] [SEC Form 424B3 filed by Panbela Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-424b3-filed-by-panbela-therapeutics-inc-5777999)
- 2024-11-15 11:12 UTC [SEC Form 424B3] [SEC Form 424B3 filed by Panbela Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-424b3-filed-by-panbela-therapeutics-inc-5777981)
- 2024-11-15 11:09 UTC [SEC Form 424B3] [SEC Form 424B3 filed by Panbela Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-424b3-filed-by-panbela-therapeutics-inc-5777974)
- 2024-11-15 11:12 UTC [SEC Form 424B3] [SEC Form 424B3 filed by Panbela Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-424b3-filed-by-panbela-therapeutics-inc-5777973)
- 2024-11-15 11:03 UTC [SEC Form 424B3] [SEC Form 424B3 filed by Panbela Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-424b3-filed-by-panbela-therapeutics-inc-5777964)
- 2024-11-15 11:06 UTC [SEC Form 424B3] [SEC Form 424B3 filed by Panbela Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-424b3-filed-by-panbela-therapeutics-inc-5777957)
- 2024-11-14 21:16 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Panbela Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-panbela-therapeutics-inc-5776044)
- 2024-11-14 21:12 UTC [SEC Form 8-K] [Panbela Therapeutics Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits](https://www.quantisnow.com/insight/panbela-therapeutics-inc-filed-sec-form-8-k-results-of-operations-5775868)
- 2024-11-14 21:10 UTC [Public Offering] [Panbela Provides Business Update and Reports Q3 2024 Financial Results](https://www.quantisnow.com/insight/panbela-provides-business-update-and-reports-q3-2024-financial-results-5775777)
- 2024-10-31 12:00 UTC [Earnings Date] [Panbela to Host Third Quarter 2024 Earnings Conference Call on November 14, 2024](https://www.quantisnow.com/insight/panbela-to-host-third-quarter-2024-earnings-conference-call-on-5745456)
- 2024-10-29 23:40 UTC [SEC Schedule 13D] [SEC Form SC 13D filed by Panbela Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-sc-13d-filed-by-panbela-therapeutics-inc-5742435)
- 2024-10-29 23:38 UTC [SEC Form 3] [SEC Form 3 filed by new insider Nant Capital, Llc](https://www.quantisnow.com/insight/sec-form-3-filed-by-new-insider-nant-capital-llc-5742434)
- 2024-10-29 13:27 UTC [SEC Form 424B3] [SEC Form 424B3 filed by Panbela Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-424b3-filed-by-panbela-therapeutics-inc-5741235)
- 2024-10-29 13:26 UTC [SEC Form 424B3] [SEC Form 424B3 filed by Panbela Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-424b3-filed-by-panbela-therapeutics-inc-5741234)
- 2024-10-29 13:26 UTC [SEC Form 424B3] [SEC Form 424B3 filed by Panbela Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-424b3-filed-by-panbela-therapeutics-inc-5741233)
- 2024-10-29 13:25 UTC [SEC Form 424B3] [SEC Form 424B3 filed by Panbela Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-424b3-filed-by-panbela-therapeutics-inc-5741232)
- 2024-10-29 13:25 UTC [SEC Form 424B3] [SEC Form 424B3 filed by Panbela Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-424b3-filed-by-panbela-therapeutics-inc-5741230)
- 2024-10-29 13:24 UTC [SEC Form 424B3] [SEC Form 424B3 filed by Panbela Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-424b3-filed-by-panbela-therapeutics-inc-5741229)
- 2024-10-29 13:24 UTC [SEC Form 424B3] [SEC Form 424B3 filed by Panbela Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-424b3-filed-by-panbela-therapeutics-inc-5741228)
- 2024-10-28 21:16 UTC [SEC Form 8-K] [Panbela Therapeutics Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Unregistered Sales of Equity Securities, Financial Statements and Exhibits](https://www.quantisnow.com/insight/panbela-therapeutics-inc-filed-sec-form-8-k-entry-into-a-5740388)
- 2024-10-03 20:26 UTC [SEC Form 4] [SEC Form 4 filed by V.P. of Finance & CFO Horvath Susan](https://www.quantisnow.com/insight/sec-form-4-filed-by-vp-of-finance-cfo-horvath-5715464)
- 2024-10-03 20:25 UTC [SEC Form 4] [SEC Form 4 filed by President and CEO Simpson Jennifer K.](https://www.quantisnow.com/insight/sec-form-4-filed-by-president-and-ceo-simpson-jennifer-5715459)
- 2024-09-27 20:34 UTC [SEC Form 8-K] [Panbela Therapeutics Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits](https://www.quantisnow.com/insight/panbela-therapeutics-inc-filed-sec-form-8-k-leadership-update-financial-5707215)
- 2024-09-24 12:00 UTC [First Patient Enrolled in Phase I Program in STK11 Mutant Non-Small Cell Lung Cancer at Moffitt Cancer Center](https://www.quantisnow.com/insight/first-patient-enrolled-in-phase-i-program-in-stk11-mutant-5702849)
- 2024-08-16 21:25 UTC [SEC Form S-1] [Amendment: SEC Form S-1/A filed by Panbela Therapeutics Inc.](https://www.quantisnow.com/insight/amendment-sec-form-s-1a-filed-by-panbela-therapeutics-inc-5663291)
- 2024-08-14 00:42 UTC [SEC Form 424B3] [SEC Form 424B3 filed by Panbela Therapeutics Inc.](https://www.quantisnow.com/insight/sec-form-424b3-filed-by-panbela-therapeutics-inc-5657948)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/PBLA
- Earnings history: https://www.quantisnow.com/earnings/PBLA
- Dividend history: https://www.quantisnow.com/dividends/PBLA
- Insider transactions: https://www.quantisnow.com/insiders/PBLA
- Options chain: https://www.quantisnow.com/options/PBLA
- SEC 8-K filings only: https://www.quantisnow.com/company/PBLA/8-k
- RSS and alerts for PBLA: https://www.quantisnow.com/docs/rss-feeds.md
